
Pharmacally
COPD Exacerbation
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in COPD Exacerbation
Clinical TrialsMerck Advances Ohtuvayre into Phase 3 COPD Exacerbation TrialMerck has initiated the Phase 3 ENHANCE-3 trial to evaluate whether Ohtuvayre (ensifentrine), added to standard-of-care therapy, can reduce moderate or severe COPD exacerbations.Fact-Checked
Clinical TrialsRademikibart Reduces Treatment Failure by 81% in Phase 2 COPD Exacerbation StudyConnect Biopharma announced positive preliminary Phase 2 topline results for rademikibart, demonstrating an 81% reduction in treatment failure and an 85% reduction in moderate-to-severe exacerbations in adults with…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.